MR-proANP levels in Acute ischemic stroke and clinical outcomes: a systematic review and meta-analysis
Neurosurgical Review · 05.11.2024 · 47 (1)
DOI: 10.1007/s10143-024-03073-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neurosurgical Review, online erschienen am 05.11.2024. Verfasst von Basel Musmar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Neurology, Duke University Hospital, Durham, NC, USA. baselmusmar33@gmail.com. Hauptthemen laut MEDLINE: Atrial Natriuretic Factor, Ischemic Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
In patients with acute ischemic stroke, midregional proatrial natriuretic peptide (MR-proANP) has shown promise in preliminary studies for risk stratification. The objective of this study is to evaluate the prognostic utility of MR-proANP in AIS, focusing on its ability to predict 90-day functional outcomes, mortality rates, and the presence of atrial fibrillation (Afib). A comprehensive literature search was conducted using PubMed, Web of Science, and Scopus, following PRISMA guidelines. The search strategy employed a combination of keywords and index terms including "Acute Ischemic Stroke," "AIS," "Cerebral Infarction," "Atrial Fibrillation," "AFib," "stroke," "MR-proANP," "Mid-regional pro-atrial natriuretic peptide," and "proatrial natriuretic peptide." Inclusion criteria encompassed any study focusing on MR-proANP and ischemic stroke, published up to October 15, 2023. Primary end points were newly diagnosed Afib, 90-day Modified Rankin Scale (mRS) score, and 90-day mortality. Studies were described in narrative and tabular form. Risk of bias was assessed using the ROBINS-I tool. Pooled estimates for our key end points were generated using a random effects model where appropriate. MR-proANP levels were significantly elevated in newly diagnosed Afib patients compared to no Afib patients (mean difference (MD): 134.4 pmol/l; 95% confidence interval (CI): 119.45 to 149.35, P < 0.0001). Unfavorable functional outcomes, as measured by mRS scores of ≥ 3 at 90 days, were associated with higher levels of MR-proANP (MD: 93.87 pmol/; 95% CI: 76.66 to 111.09, P < 0.0001). Elevated MR-proANP levels were also strongly correlated with increased 90-day mortality rates (MD: 164.43 pmol/; CI: 95.94 to 232.92, P < 0.0001). MR-proANP was significantly associated with functional outcomes, 90-day mortality, and the newly diagnosed AF. The limited number of studies included calls for further large-scale research to confirm these findings and explore the potential for expedited diagnostic procedures and targeted interventions like anticoagulant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and Neurology, Duke University Hospital, Durham, NC, USA. baselmusmar33@gmail.com.
- Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, USA. baselmusmar33@gmail.com.
- Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, Shreveport, LA, USA.
- Department of Neurosurgery and Neurology, Duke University Hospital, Durham, NC, USA.
- Department of Biomedical Engineering, Erciyes University, Kayseri, Turkey.
Zitieren
APA
Musmar, B., Salim, H. A., Mac Grory, B., Musmar, F., Spellicy, S., Abdelgadir, J., Adeeb, N., & Hasan, D. (2024). MR-proANP levels in Acute ischemic stroke and clinical outcomes: a systematic review and meta-analysis. Neurosurgical Review, 47(1). https://doi.org/10.1007/s10143-024-03073-w
Vancouver
Musmar B, Salim HA, Mac Grory B, Musmar F, Spellicy S, Abdelgadir J, et al. MR-proANP levels in Acute ischemic stroke and clinical outcomes: a systematic review and meta-analysis. Neurosurgical Review. 2024;47(1). doi:10.1007/s10143-024-03073-w
BibTeX
@article{Musmar2024,
author = {Musmar, Basel and Salim, Hamza Adel and Mac Grory, Brian and Musmar, Fares and Spellicy, Samantha and Abdelgadir, Jihad and Adeeb, Nimer and Hasan, David},
title = {MR-proANP levels in Acute ischemic stroke and clinical outcomes: a systematic review and meta-analysis},
journal = {Neurosurgical Review},
year = {2024},
volume = {47},
number = {1},
doi = {10.1007/s10143-024-03073-w}
}
EUVIMED